Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer Radmila LemstrovaBohuslav MelicharBeatrice Mohelnikova-Duchonova Review Article 01 June 2016 Pages: 1101 - 1111
Application of bee venom and its main constituent melittin for cancer treatment Cui-cui LiuDing-jun HaoHao Yang Review Article 27 September 2016 Pages: 1113 - 1130
Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer May GarrettTimothy TaylorYazdi K. Pithavala Original Article 25 October 2016 Pages: 1131 - 1141
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle Ziyou WangHua ZhangZunnan Huang Original Article 20 October 2016 Pages: 1143 - 1150
Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells Guodong HeChen FengWei Wu Original Article 27 October 2016 Pages: 1151 - 1161
GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis Xiangzhen KongZihao LiXian Li Original Article 26 October 2016 Pages: 1163 - 1173
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial Miriam KrischkeGeorg HempelJoachim Boos Original Article Open access 21 October 2016 Pages: 1175 - 1184
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function Analía AzaroJordi RodónMaja J. A. de Jonge Original Article Open access 27 October 2016 Pages: 1185 - 1197
RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis Chenggang LiZhiming ZhaoRong Liu Original Article 26 October 2016 Pages: 1199 - 1207
Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane Motoo NomuraSatoru IwasaKei Muro Original Article 24 October 2016 Pages: 1209 - 1216
Pharmacokinetics, immunogenicity, and safety of weekly dosing of brentuximab vedotin in pediatric patients with Hodgkin lymphoma Jamie E. FlerlageMonika L. MetzgerJohn C. Panetta Original Article 11 November 2016 Pages: 1217 - 1223
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation Brian F. KieselRobert A. PariseJulie L. Eiseman Original Article 24 October 2016 Pages: 1225 - 1235
Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma Chaitali PasseyRaymond DarbenzioManish Gupta Original Article 28 October 2016 Pages: 1237 - 1244
18F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen Matthew ScarpelliJustine Yang BruceGlenn Liu Original Article 05 November 2016 Pages: 1245 - 1252
Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial Tadamichi DendaMitsuro KandaHideyuki Mishima Original Article 02 November 2016 Pages: 1253 - 1261
Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer In Hee LeeSoo Jung LeeJong Gwang Kim Original Article 09 November 2016 Pages: 1263 - 1267
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037 Emma J. HaagensenHuw D. ThomasDavid R. Newell Original Article Open access 11 November 2016 Pages: 1269 - 1281
Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas T. EbataM. YunokawaK. Tamura Original Article 10 November 2016 Pages: 1283 - 1288
Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity Zhiqiang ZhangYunmin WangMei Wang Original Article 10 November 2016 Pages: 1289 - 1296
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer Benjamin L. MaughanDaniel L. SuzmanEmmanuel S. Antonarakis Original Article 08 November 2016 Pages: 1297 - 1304
EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases Jing ZhaoXin YeMengzhao Wang Short Communication 21 October 2016 Pages: 1305 - 1310
Aromatase inhibitor-induced carpal tunnel syndrome: prevalence in daily practice Labidi SoumayaMejri NesrineBoussen Hamouda Short Communication 05 November 2016 Pages: 1311 - 1315
Gota et al. on their article “the pharmacokinetics of Reditux™, a biosimilar of rituximab” Mira ToutChristophe PassotDavid Ternant Letter to the Editor 17 October 2016 Pages: 1317 - 1318